Tango Therapeutics (TNGX) Change in Account Payables (2020 - 2026)
Tango Therapeutics has reported Change in Account Payables over the past 6 years, most recently at -$1.2 million for Q4 2025.
- For Q4 2025, Change in Account Payables rose 50.9% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$825000.0, up 30.32%, while the annual FY2025 figure was -$825000.0, 30.32% up from the prior year.
- Change in Account Payables for Q4 2025 was -$1.2 million at Tango Therapeutics, down from -$344000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $4.5 million in Q3 2022 and troughed at -$2.8 million in Q2 2024.
- A 5-year average of -$69250.0 and a median of -$351500.0 in 2022 define the central range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 43536.36% in 2021 and fell as far as 36537.56% in 2021.
- Year by year, Change in Account Payables stood at $365000.0 in 2021, then plummeted by 384.93% to -$1.0 million in 2022, then skyrocketed by 91.54% to -$88000.0 in 2023, then tumbled by 2748.86% to -$2.5 million in 2024, then surged by 50.9% to -$1.2 million in 2025.
- Business Quant data shows Change in Account Payables for TNGX at -$1.2 million in Q4 2025, -$344000.0 in Q3 2025, and -$880000.0 in Q2 2025.